Company Filing History:
Years Active: 2013-2016
Title: Souhei Ohyama: Innovator in Anti-NR10 Antibodies
Introduction
Souhei Ohyama is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in inflammatory diseases. With a total of 2 patents to his name, Ohyama's work is paving the way for new therapeutic options.
Latest Patents
Ohyama's latest patents include "Nucleic acids encoding anti-NR10 antibodies" and "Anti-NR10 antibody and use thereof." In these inventions, the present inventors successfully obtained anti-NR10 antibodies that exhibit effective neutralizing activity against NR10. These antibodies are particularly useful as pharmaceuticals for treating or preventing inflammatory diseases, showcasing the potential impact of his research on healthcare.
Career Highlights
Ohyama is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His role at the company allows him to further his research and development efforts in the field of antibody therapeutics. His innovative work has garnered attention within the scientific community and has the potential to lead to significant advancements in medical treatments.
Collaborations
Ohyama has collaborated with notable colleagues such as Taichi Kuramochi and Keiko Kasutani. These partnerships have contributed to the successful development of his patents and have fostered a collaborative environment for innovation.
Conclusion
Souhei Ohyama's contributions to the field of biotechnology, particularly through his patents on anti-NR10 antibodies, highlight his role as a key innovator in the industry. His work not only advances scientific knowledge but also holds promise for improving therapeutic options for patients suffering from inflammatory diseases.